Show simple item record

dc.contributor.authorFuentes-Hernandez, A
dc.contributor.authorPlucain, J
dc.contributor.authorGori, F
dc.contributor.authorPena-Miller, R
dc.contributor.authorReding, C
dc.contributor.authorJansen, G
dc.contributor.authorSchulenburg, H
dc.contributor.authorGudelj, I
dc.contributor.authorBeardmore, Robert
dc.date.accessioned2016-02-12T09:24:46Z
dc.date.issued2015-04-08
dc.description.abstractWe need to find ways of enhancing the potency of existing antibiotics, and, with this in mind, we begin with an unusual question: how low can antibiotic dosages be and yet bacterial clearance still be observed? Seeking to optimise the simultaneous use of two antibiotics, we use the minimal dose at which clearance is observed in an in vitro experimental model of antibiotic treatment as a criterion to distinguish the best and worst treatments of a bacterium, Escherichia coli. Our aim is to compare a combination treatment consisting of two synergistic antibiotics to so-called sequential treatments in which the choice of antibiotic to administer can change with each round of treatment. Using mathematical predictions validated by the E. coli treatment model, we show that clearance of the bacterium can be achieved using sequential treatments at antibiotic dosages so low that the equivalent two-drug combination treatments are ineffective. Seeking to treat the bacterium in testing circumstances, we purposefully study an E. coli strain that has a multidrug pump encoded in its chromosome that effluxes both antibiotics. Genomic amplifications that increase the number of pumps expressed per cell can cause the failure of high-dose combination treatments, yet, as we show, sequentially treated populations can still collapse. However, dual resistance due to the pump means that the antibiotics must be carefully deployed and not all sublethal sequential treatments succeed. A screen of 136 96-h-long sequential treatments determined five of these that could clear the bacterium at sublethal dosages in all replicate populations, even though none had done so by 24 h. These successes can be attributed to a collateral sensitivity whereby cross-resistance due to the duplicated pump proves insufficient to stop a reduction in E. coli growth rate following drug exchanges, a reduction that proves large enough for appropriately chosen drug switches to clear the bacterium.en_GB
dc.description.sponsorshipEPSRCen_GB
dc.identifier.citationVol. 13, Iss. 4, pp. e1002104 -en_GB
dc.identifier.doi10.1371/journal.pbio.1002104
dc.identifier.grantnumberEP/I00503X/1en_GB
dc.identifier.grantnumberEP/I018263/1en_GB
dc.identifier.otherPBIOLOGY-D-14-03336
dc.identifier.urihttp://hdl.handle.net/10871/19751
dc.language.isoenen_GB
dc.publisherPublic Library of Scienceen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/25853342en_GB
dc.relation.urlhttp://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002104en_GB
dc.rightsCopyright © 2015 Fuentes-Hernandez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are crediteden_GB
dc.titleUsing a sequential regimen to eliminate bacteria at sublethal antibiotic dosages.en_GB
dc.typeArticleen_GB
dc.date.available2016-02-12T09:24:46Z
dc.identifier.issn1544-9173
exeter.place-of-publicationUnited States
dc.descriptionPublished onlineen_GB
dc.descriptionJournal Articleen_GB
dc.descriptionResearch Support, Non-U.S. Gov'ten_GB
dc.identifier.eissn1545-7885
dc.identifier.journalPLoS Biologyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record